Victory Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Sell |
|
|||||
|
2025
Q1 | $12.4K | Buy |
|
|||||
|
2024
Q4 | $13.6K | Buy |
|
|||||
|
2024
Q3 | $21.6K | Sell |
|
|||||
|
2024
Q2 | $24.2K | Sell |
|
|||||
|
2024
Q1 | $36.5K | Buy |
|
|||||
|
2023
Q4 | $25.6K | Buy |
|
|||||
|
2023
Q3 | $22.7K | Buy |
|
|||||
|
2023
Q2 | $26K | Sell |
|
|||||
|
2023
Q1 | $28.3K | Sell |
|
|||||
|
2022
Q4 | $22.3K | Sell |
|
|||||
|
2022
Q3 | $22K | Sell |
|
|||||
|
2022
Q2 | $36K | Buy |
|
|||||
|
2022
Q1 | $27K | Sell |
|
|||||
|
2021
Q4 | $58K | Sell |
|
|||||
|
2021
Q3 | $61K | Sell |
|
|||||
|
2021
Q2 | $70K | Buy |
|
|||||
|
2021
Q1 | $55K | Sell |
|
|||||
|
2020
Q4 | $42K | Buy |
|
|||||
|
2020
Q3 | $21K | Sell |
|
|||||
|
2020
Q2 | $21K | Sell |
|
|||||
|
2020
Q1 | $42K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $25K | Buy |
|